uniQure QURE
NASDAQ QURE
$44.50 -0.36 (-0.80%)
As of: Sep 4, 2026 · 3:59 PM EDT

uniQure (QURE) Net Equity Issued and Repurchased (2016 - 2021)

uniQure (QURE) posted quarterly Net Equity Issued and Repurchased of $2.2 million for Q2 2021, down 14.73% year-over-year from $2.5 million in Q2 2020, and down 92.47% quarter-over-quarter from $28.7 million in Q1 2021.

Analysis

uniQure (QURE) Net Equity Issued and Repurchased (2016 - 2021) Analysis & Trends

uniQure's Net Equity Issued and Repurchased history runs 6 years deep, the most recent figure standing at $2.2 million for Q2 2021.

  • In Q2 2021, Net Equity Issued and Repurchased fell 14.73% year-over-year to $2.2 million; the TTM figure through Dec 2021 stood at $30.9 million (up 315.09% YoY), while the FY2021 annual figure was $30.9 million, up 315.09% from the prior year.
  • Net Equity Issued and Repurchased for Q2 2021 stood at $2.2 million, down from $28.7 million in the prior quarter.
  • The five-year high for Net Equity Issued and Repurchased was $28.7 million in Q1 2021, with the low at $97000.0 in Q3 2017.
  • The 5-year median for Net Equity Issued and Repurchased is $1.5 million (2018), against an average of $2.9 million.
  • The sharpest annual moves came in 2018 and 2021: Net Equity Issued and Repurchased slumped 93.75% in 2018, then jumped 2744.95% in 2021.
  • uniQure's Net Equity Issued and Repurchased stood at $3.0 million in 2017, then plunged by 93.75% to $188000.0 in 2018, then soared by 753.72% to $1.6 million in 2019, then jumped by 134.02% to $3.8 million in 2020, then plunged by 42.36% to $2.2 million in 2021.
  • Business Quant data shows QURE's Net Equity Issued and Repurchased at $2.2 million in Q2 2021, $28.7 million in Q1 2021, and $3.8 million in Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 49.20 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 141.90 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 uniQure 2.95 Bn 2.95 Bn 5.49 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 2.17 Mn
Mar 31, 2021 28.73 Mn
Dec 31, 2020 3.76 Mn
Sep 30, 2020 139,000.00
Jun 30, 2020 2.54 Mn
Mar 31, 2020 1.01 Mn
Dec 31, 2019 1.61 Mn
Sep 30, 2019 1.28 Mn
Jun 30, 2019 543,000.00
Mar 31, 2019 2.18 Mn
Dec 31, 2018 188,000.00
Sep 30, 2018 1.65 Mn
Jun 30, 2018 1.43 Mn
Mar 31, 2018 1.56 Mn
Dec 31, 2017 3.01 Mn
Sep 30, 2017 97,000.00
Jun 30, 2017 498,000.00
Mar 31, 2017 441,000.00
Dec 31, 2016 375,000.00
Sep 30, 2016 23,000.00